Fetuin-A: a novel link between obesity and related complications. (Q38282015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

review article

1 reference

title

Fetuin-A: a novel link between obesity and related complications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

J F Trepanowski

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

K A Varady

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

3 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

734-741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ijo.2014.203

24 February 2020

exact match

0 references

cites work

Fetuin-A and incident diabetes mellitus in older persons

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Plasma fetuin-A levels and the risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-B, a second member of the fetuin family in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-A induces cytokine expression and suppresses adiponectin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-mineral complex reflects extraosseous calcification stress in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

The role of hepatokines in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-A and change in body composition in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Insulin-sensitive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

AHSG gene variant is associated with leanness among Swedish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Causal relationship between body mass index and fetuin-A level in the asian population: a bidirectional Mendelian randomization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white Danish subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Genetically elevated fetuin-A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Nanoparticle-based test measures overall propensity for calcification in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Serum calcification propensity predicts all-cause mortality in predialysis CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

A sustained increase in plasma NEFA upregulates the Toll-like receptor network in human muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

High glucose induces transactivation of the alpha2-HS glycoprotein gene through the ERK1/2 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Adipocyte fetuin-A contributes to macrophage migration into adipose tissue and polarization of macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-null mice are protected against obesity and insulin resistance associated with aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD β-subunit of the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Polymorphism of the AHSG gene is associated with increased adipocyte beta2-adrenoceptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Lower fetuin-A, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

The effect of 6-weeks of aerobic exercise training on serum fetuin-A levels in non-diabetic obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

AMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Deoxyribonucleotides as genetic and metabolic regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

Fetuin, a New Globulin Isolated from Serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.203

The effects of caloric restriction on fetuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial

21 January 2018

1 reference

12 December 2020

Raised circulating fetuin-a after 28-day overfeeding in healthy humans

1 reference

12 December 2020

Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD

1 reference

12 December 2020

Serum fetuin-A in metabolic and inflammatory pathways in patients with myocardial infarction

1 reference

12 December 2020

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

12 December 2020

Secretion of a major phosphorylated glycoprotein by hepatocytes. Characterization of specific antibodies and investigations of the processing, excretion kinetics, and phosphorylation

1 reference

12 December 2020

Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis

1 reference

12 December 2020

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

1 reference

12 December 2020

Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma

1 reference

12 December 2020

Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects

1 reference

12 December 2020

Alpha2-Heremans Schmid glycoprotein inhibits insulin-stimulated Elk-1 phosphorylation, but not glucose transport, in rat adipose cells

1 reference

12 December 2020

Fetuin-B, a second member of the fetuin family in mammals

1 reference

12 December 2020

Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance

1 reference

12 December 2020

Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase

1 reference

12 December 2020

A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians

1 reference

12 December 2020

Vascular calcification: from pathophysiology to biomarkers

1 reference

12 December 2020

Recombinant human alpha 2-HS glycoprotein inhibits insulin-stimulated mitogenic pathway without affecting metabolic signalling in Chinese hamster ovary cells overexpressing the human insulin receptor

1 reference

12 December 2020

Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes: Response to Eraso et al

1 reference

12 December 2020

Identifiers

DOI

10.1038/IJO.2014.203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25468829%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

24 February 2020

0 references

1 reference